L-Cyclohexylalanine

CAS No. 27527-05-5

L-Cyclohexylalanine( —— )

Catalog No. M37054 CAS No. 27527-05-5

L-Cyclohexylalanine (L-3-Cyclohexylalanine) is an amino acid analog that binds to the heavy enzyme thioester of the short peptide S synthase.=

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Cyclohexylalanine
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Cyclohexylalanine (L-3-Cyclohexylalanine) is an amino acid analog that binds to the heavy enzyme thioester of the short peptide S synthase.=
  • Description
    L-Cyclohexylalanine (L-3-Cyclohexylalanine) is an amino acid analog that binds to the heavy enzyme thioester of the short peptide S synthase.L-Cyclohexylalanine can be used to synthesize anticoagulant decapeptides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    27527-05-5
  • Formula Weight
    171.24
  • Molecular Formula
    C9H17NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N[C@@H](CC1CCCCC1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ellagic acid 3-O-α-L...

    Ellagic acid 3-O-α-L-rhamnopyranoside is a natural product found in the tuberous roots of [Potentilla anserina].

  • DMG-PEG2000

    DMG-PEG2000 is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles.

  • MID-1

    MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.